Optimal treatment for malignant hyperthermia today.
Krivosic-Horber
R
R
C.H.R., Lille, France.
D000758:Anesthesia / Q000379:methods; D002985:Clinical Protocols; D003422:Critical Care / Q000379:methods*; D003620:Dantrolene / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008305:Malignant Hyperthermia / Q000517:prevention & control / Q000628:therapy*; D011182:Postoperative Care / Q000379:methods; D012307:Risk Factors
D003620:Dantrolene